The Wharton Moneyball Post Game Podcast


Wharton Moneyball - 1/15/20: Seth Walder, Alexandra Mandrycky

Seth Walder has been a sports analytics writer at ESPN since 2017, focusing on football and basketball coverage using quantitative metrics. His work includes topics ranging from season projections to player analysis based on NFL Next Gen Stats. He writes for and makes regular appearances across ESPN studio programming.

Prior to joining ESPN, he worked as a reporter for the New York Daily News for six years, primarily covering the New York Jets and New York Giants, with occasional analysis of the New York MLB, NBA and NHL teams as well as high school sports.

The London native attended Bowdoin College in Brunswick, Maine and was editor in chief of the Bowdoin Orient, while majoring in government studies.

Alexandra Mandrycky is the Director of Hockey Administration for the NHL’s forthcoming Seattle franchise where she leads on hockey strategy & research. Prior to joining the Seattle franchise, Alexandra worked in the Minnesota Wild’s front office.

The team will begin play for the 2021 season and it will be the first professional hockey team to play in Seattle since the Seattle Totems of the Western Hockey League played their last game in 1975. 

More Episodes


7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.